Evidence map›Paper›PMID 30296341›Full record

ArticleHepatology (Baltimore, Md.)2019

Cholangiocyte-to-Hepatocyte Differentiation: A Context-Dependent Process and an Opportunity for Regenerative Medicine.

Maria J Perugorria, Paula Olaizola, Jesus M Banales

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Maria J PerugorriaDepartment of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
Paula OlaizolaDepartment of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
Jesus M BanalesDepartment of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.

Funding

AECC Scientific FoundationBasque Government PRE_2016_1_0152BIOEF BIO15/CA/016/BDDepartment of Health of the Basque Country 2015111100Department of Health of the Basque Country 2017111010Diputación Foral de Gipuzkoa DFG15/010Diputación Foral de Gipuzkoa DFG16/004Diputación Foral de Gipuzkoa DFG1818/114ISCIII CIBERehdMiguel Servet Programme CON14/00129Miguel Servet Programme FIS PI14/00399Miguel Servet Programme FIS PI17/00022Ramon y Cajal Programme RYC-2015-17755Spanish Ministries of Economy and Competitiveness FIS PI12/00380Spanish Ministries of Economy and Competitiveness FIS PI15/01132Spanish Ministries of Economy and Competitiveness PI18/01075
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beta CateninRegenerative MedicineCell DifferentiationHepatocytesLiverbeta Catenin

Identifiers

PMID30296341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.